Lightstone’s largest fund yet: $375M for biotech, medtech
Although Lightstone is staying in its wheelhouse by splitting its third and largest fund between biotech and medtech, the fund’s size will allow the VC to write larger checks to keep pace with the growing size of life sciences financings.
Lightstone Ventures said Tuesday it closed Lightstone Ventures III at $375 million. Partner Christina Isacson told BioCentury the oversubscribed fund came in above the firm’s target of $300-$350 million...